Published in Tubercle on March 01, 1991
Tuberculin testing before BCG vaccination. BMJ (2003) 1.42
Effective vaccination against tuberculosis-a new ray of hope. Clin Exp Immunol (2000) 0.87
Tuberculosis and HIV: light after darkness. Thorax (1994) 0.84
Measurements of blood flow and histometry of the cellular infiltrate in tuberculin skin test responses of the typical Koch type and the non-turgid variant form (Listeria-type) in pulmonary tuberculosis patients and apparently healthy controls. Int J Exp Pathol (1992) 0.75
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis (1998) 5.51
Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J Appl Bacteriol (1992) 4.83
The meaning and structure of species as applied to mycobacteria. Tubercle (1974) 3.22
Mycobacteria in water. J Appl Bacteriol (1984) 3.04
Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J Clin Microbiol (1988) 2.79
The bovine tubercle bacillus. J Appl Bacteriol (1983) 2.72
The zoonotic importance of Mycobacterium bovis. Tuber Lung Dis (1996) 2.50
Subdivision of Mycobacterium tuberculosis into five variants for epidemiological purposes: methods and nomenclature. J Hyg (Lond) (1982) 2.43
The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness. Adv Tuberc Res (1984) 2.43
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38
Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J (2010) 2.38
Tuberculosis and the kidney. J Am Soc Nephrol (2001) 2.34
A study of bovine strains of Mycobacterium tuberculosis isolated from humans in South-East England, 1977-1979. Tubercle (1981) 2.20
HIV/AIDS and its implications for the control of animal tuberculosis. Br Vet J (1994) 2.20
Is Africa lost? Lancet (1991) 2.08
The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection. J Hyg (Lond) (1975) 2.02
Mycolic acid patterns of representative strains of Mycobacterium fortuitum, 'Myobacterium peregrinum' and Mycobacterium smegmatis. J Gen Microbiol (1984) 1.67
Complementary medicine in the medical curriculum. J R Soc Med (1997) 1.67
Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis and Crohn's disease. Tubercle (1980) 1.65
Subdivision of Mycobacterium tuberculosis for epidemiological purposes: a seven year study of the "Classical' and 'Asian' types of the human tubercle bacillus in South-East England. J Hyg (Lond) (1985) 1.61
A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle (1985) 1.57
Use of umbelliferone derivatives in the study of enzyme activities of mycobacteria. J Clin Pathol (1977) 1.56
The correlation of bacteriophage types of Mycobacterium tuberculosis with guinea-pig virulence and in vitro-indicators of virulence. J Gen Microbiol (1978) 1.55
Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa. Rev Sci Tech (1995) 1.53
A study of Mycobacterium fortuitum (ranae). J Med Microbiol (1974) 1.51
T4 lymphopenia in patients with active pulmonary tuberculosis. Clin Exp Immunol (1985) 1.50
Immunodiagnostic assays for tuberculosis and leprosy. Br Med Bull (1988) 1.49
The nature of mycobacterial disease in south east England, 1977-84. J Epidemiol Community Health (1986) 1.47
Infections caused by opportunist mycobacteria: a review. J R Soc Med (1986) 1.47
Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis (2005) 1.46
Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis? Respir Med (2001) 1.44
The tuberculosis pandemic: implications for health in the tropics. Trans R Soc Trop Med Hyg (1999) 1.43
A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis (1999) 1.43
Mycobacterium marinum infections in man. J Hyg (Lond) (1985) 1.42
Incidence and nature of human tuberculosis due to bovine tubercle bacilli in South-East England: 1977-1987. Epidemiol Infect (1988) 1.35
"Classical" and "Asian" variants of Mycobacterium tuberculosis isolated in South East England 1977-1980. Tubercle (1982) 1.35
Isolation of mycobacteria from patients seropositive for the human immunodeficiency virus (HIV) in south east England: 1984-92. Thorax (1993) 1.34
Tuberculosis and the acquired immune deficiency syndrome. J Appl Bacteriol (1991) 1.34
Tuberculosis: the changing tubercle. Br J Hosp Med (1979) 1.31
The tuberculosis pandemic--which way now? J Infect (1999) 1.24
A study of acute-phase reactant proteins in Indonesian patients with pulmonary tuberculosis. Tubercle (1984) 1.22
Impact of HIV infection on tuberculosis. Postgrad Med J (2000) 1.20
Specificity of antibodies and tuberculin response after occupational exposure to tuberculosis. J Infect Dis (1992) 1.18
Differentiation of BCG from other variants of Mycobacterium tuberculosis isolated from clinical material. Tubercle (1978) 1.18
Levels of antibody to defined antigens of Mycobacterium tuberculosis in tuberculous meningitis. J Clin Microbiol (1989) 1.18
Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy. Tubercle (1989) 1.18
Tuberculosis preventive therapy: perspective from a multi-ethnic community. Respir Med (2000) 1.15
Establishing a united front against the injustice of tuberculosis. Int J Tuberc Lung Dis (1998) 1.13
Role of lipid content and hydrogen peroxide susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis. Br J Exp Pathol (1982) 1.13
Isolation of environmental mycobacteria from clinical specimens in south-east England: 1973-1993. Int J Tuberc Lung Dis (1997) 1.13
Bacteriological survey of tuberculous lymphadenitis in southeast England, 1981-1989. J Epidemiol Community Health (1992) 1.12
A study of the relationship between the resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide (isoniazid) and to thiophen-2-carboxylic acid hydrazide. Tubercle (1984) 1.10
The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin A. Clin Exp Immunol (1986) 1.10
A bacteriological survey of tuberculosis due to the human tubercle bacillus (Mycobacterium tuberculosis) in south-east England: 1984-91. Epidemiol Infect (1993) 1.09
HIV-related tuberculosis due to Mycobacterium bovis. Eur Respir J (1994) 1.07
A fluorigenic substrate for the rapid differentiation of Mycobacterium fortuitum from Mycobacterium chelonei on the basis of heat stable esterase activity. Tubercle (1977) 1.07
Reply: honey and propolis as possible promoters of the healing of ulcers in leprosy. Lepr Rev (1990) 1.06
Immunological and clinical features of smear-positive pulmonary tuberculosis in East Java. Tubercle (1980) 1.06
Doing something about tuberculosis. BMJ (1999) 1.05
The genetics of mycobacteria and mycobacteriophages - a review. Tubercle (1975) 1.03
The promise of immunotherapy for tuberculosis. Respir Med (1994) 1.03
Nomenclature of mycobacterial disease. Am Rev Respir Dis (1989) 1.03
The mystery of the mycobacterial 'persistor'. Tuber Lung Dis (1992) 1.02
Phage typing of Mycobacterium kansasii. Tubercle (1980) 1.01
Tuberculosis acquired in laboratories and necropsy rooms. Commun Dis Public Health (1999) 1.01
New concepts for the control of tuberculosis in the twenty first century. J R Coll Physicians Lond (1993) 1.00
Bacteriophage typing of Mycobacterium tuberculosis strains isolated in South East England. Tubercle (1976) 1.00
The bovine tuberculosis cycle--an African perspective. Soc Appl Bacteriol Symp Ser (1996) 0.99
Diversity in migration of CD4 and CD8 lymphocytes in different microanatomical compartments of the skin in the tuberculin reaction in man. Br J Exp Pathol (1988) 0.99
Mycobacterium chelonei. Tubercle (1981) 0.98
Infection and disease due to the environmental mycobacteria. Trans R Soc Trop Med Hyg (1987) 0.97
Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. Eur J Cancer (2003) 0.97
What is BCG? Tubercle (1983) 0.96
Names for mycobacteria. Br Med J (Clin Res Ed) (1984) 0.96
A study of the effects of intradermal administration of recombinant gamma interferon in lepromatous leprosy patients. Lepr Rev (1987) 0.94
Cold fingers in leprosy. Int J Lepr Other Mycobact Dis (1992) 0.94
Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung. Eur J Cancer (2007) 0.94
Inoculation mycobacterioses. Clin Exp Dermatol (1988) 0.93
Old plague, new plague, and a treatment for both? AIDS (1993) 0.93
Protective role for CD8 cells in tuberculosis. Lancet (1992) 0.92
Enzymic breakdown of amino acids and related compounds by suspensions of washed mycobacteria. J Appl Bacteriol (1976) 0.92
The method of preparation of an antigen may influence the cellular reaction to it in skin tests for delayed hypersensitivity: comparison between responses to two different reagents prepared from Mycobacterium tuberculosis. Clin Exp Immunol (1987) 0.92
Multidrug-resistant tuberculosis--can the tide be turned? Lancet Infect Dis (2001) 0.91
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer (2005) 0.91
Immunotherapy: a new strategy for tuberculosis control? Respir Med (1997) 0.90
Effect of the method of preparation of bacille Calmette-Guérin (BCG) vaccine on the properties of four daughter strains. J Appl Bacteriol (1987) 0.90
Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes. Proc Natl Acad Sci U S A (1994) 0.89
Antibodies to Mycobacterium tuberculosis in leprosy. Lancet (1987) 0.89
Mycobacterium avium. Eur J Respir Dis (1984) 0.89
Environmental mycobacteria and BCG vaccination. Tubercle (1986) 0.89
The Mantoux test in tuberculosis: correlations between the diameters of the dermal responses and the serum protein levels. Tubercle (1981) 0.89
Smoking and tuberculosis: a chance or causal association? Thorax (2005) 0.88
Effective vaccination against tuberculosis-a new ray of hope. Clin Exp Immunol (2000) 0.87
Patient choice promotes adherence in preventive treatment for latent tuberculosis. Eur Respir J (2007) 0.87
Koch's Tubercle Bacillus - a centenary reappraisal. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.87
A comparison of the responsiveness to four new tuberculins among Indonesian patients with pulmonary tuberculosis and healthy subjects. Eur J Respir Dis (1986) 0.87